ATYR
aTyr Pharma (ATYR)
$84
About aTyr Pharma (ATYR)
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
Details
Daily high
$0.86
Daily low
$0.75
Price at open
$0.75
52 Week High
$7.29
52 Week Low
$0.64
Market cap
75.5M
Dividend yield
0.00%
Volume
2.7M
Avg. volume
3.5M
P/E ratio
-.92
aTyr Pharma News
Details
Daily high
$0.86
Daily low
$0.75
Price at open
$0.75
52 Week High
$7.29
52 Week Low
$0.64
Market cap
75.5M
Dividend yield
0.00%
Volume
2.7M
Avg. volume
3.5M
P/E ratio
-.92